Skip to main content

Table 4 The risk factors for chemotherapy-associated lymphopenia <0.66 × 10 9 /L in colorectal cancer by multivariate logistic regression model

From: The impact of chemotherapy-associated neutrophil/ lymphocyte counts on prognosis of adjuvant chemotherapy in colorectal cancer

Variables

Odds ratio

95% confidence intervals

P-value

Pretreatment albumin

   

≥35 g/L

1.00(ref.)

  

<35 g/L

0.685

0.302-1.550

0.363

Pretreatment CEA a

   

<10 ng ml-1

1.00(ref.)

  

≥10 ng ml-1

3.338

1.523-7.315

0.003

Differentiation

   

Well

1.00(ref.)

  

Moderately

1.200

0.308-4.678

0.793

Low

3.049

0.553-16.828

0.201

Sex

   

Male

1.00(ref.)

  

Female

1.219

0.600-2.474

0.584

Age

   

≤49 years

1.00(ref.)

  

50-60 yeas

0.840

0.271-2.608

0.763

>60 years

2.358

0.904-6.154

0.080

Location

   

Rectum

1.00(ref.)

  

Left colon cancer

1.056

0.484-2.300

0.892

Right colon cancer

0.532

0.192-1.475

0.225

Stage

   

II

1.00(ref.)

  

III

0.847

0.403-1.781

0.661

  1. a Carcinoembryonic antigen.